Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac suppository for prevention of post-cesarean section hemorrhage
IRCT20240221061071N1Phase 3Completed
- Sponsor
- Alborz University of Medical Sciences
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of diclofenac in postpartum hemorrhage (PPH), sponsored by Alborz University of Medical Sciences. Started Oct 2024; status: completed.
02
Drugs
diclofenac
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on IRCT20240221061071N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240221061071N1.